Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of MTDNA mutation
There is emerging evidence that people with successfully treated HIV infection age prematurely, leading to progressive multi-organ disease, but the reasons for this are not known.
The Strategic Role of Chemistry to Target Mitochondria will be discussed by Dr Richard Hartley
Mitochondria are central to the healthy functioning of the cell, both in terms of metabolism and signaling, but also play a key role in the process of apoptosis.
Dr Meagan McManus, from Center for Mitochondrial and Epigenomic Medicine, will introduce Targeting Mitochondria 2012 on behalf of Pr Douglas Wallace
Pr Douglas Wallace will receive the Gruber Genetics Prize for Groundbreaking Contributions to Mitochondrial Genetics. The award ceremony will be held on November 9, and it is why he invited Dr Meagan McManus to introduce Targeting Mitochondria 2012,
ISANH & Targeting Mitochondria Committees congratulate Pr Douglas C. Wallace, for his Gruber Genetics Prize for Groundbreaking Contributions to Mitochondrial Genetics
Pr Douglas C. Wallace, a pioneering genetics researcher who founded the field of mitochondrial genetics in humans, will receive the $500,000 Gruber Genetics Prize 2012 for Groundbreaking Contributions to Mitochondrial Genetics.
The Mitochondria Engineering Concept: Challenges & Limits
During Targeting Mitochondria 2012, the scientific committee selected two hot topics for 2012 edition: Mito-Devices & Mito-Engineering.
Correcting human mitochondrial mutations with targeted RNA import: A hot topic presented by M. Teitell during Targeting Mitochondria 2012
Mutations in the human mitochondrial genome are implicated in neuromuscular diseases, metabolic defects, and aging.
ISANH and Scientific Committee of Targeting Mitochondria 2011 Awarded Dr Arduino for her work
During Targeting Mitochondria 2011, the Scientific Committee awarded three researchers for their innovative projects.
SIRT2 Deacetylase activity controls the autophagy-lysosomal system by modulating the acetylation of tubulin cytoskeleton.
Ninapharm Awarded Dr Yuma Yamada for his Scientific Contribution
Dr Yamada showed the possibility of mitochondrial genome targeting using a Dual Function (DF)-MITO-Porter...
More Articles...
- Press Release - Berlin – October 15, 2011: Berlin will host the next 2nd World Congress on Targeting Mitochondria
- Original Papers of Targeting Mitochondria 2011 will be published in Mitochondrion - Guest Editor: Pr V. Weissig
- “Hyperglycemic Memory”: Permanent Cellular Damage in a Transient Insult - A Mitochondrial Perspective highlighted during Targeting Mitochondria 2011
- Among abstracts already accepted for Short Oral Presentation
